ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,982.72
-0.84%
US Tech 100
21,120.40
-1.18%
Dow Jones
42,215.80
-0.70%
Brent Oil
75.635
-0.53%
Bitcoin
104,922.70
0.31%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Keros Therapeutics Inc (KROS) Quote

Keros Therapeutics Inc

Keros Therapeutics Inc (KROS)

NASDAQ
13.46
-0.20
(-1.46%)
Closed June 17 4:00PM
15 min delayed - Upgrade to Realtime
13.46
0.00
(0.00%)
After Hours: 5:42PM
15 min delayed - Upgrade to Realtime

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
13.46
Bid
13.41
Ask
14.20
Volume
298,599
13.31 Day's Range 13.76
9.12 52 Week Range 72.37
Market Cap
546.683M
Previous Close
13.66
Open
13.60
Last Trade
2
@
13.87
Last Trade Time
Financial Volume
$ 4,058,612
VWAP
13.5922
Average Volume (3m)
1,010,425
Shares Outstanding
40,615,414
Dividend Yield
-
PE Ratio
-2.92
Earnings Per Share (EPS)
-4.61
Revenue
3.55M
Net Profit
-187.35M

About Keros Therapeutics Inc

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candida... Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.kerostx.com
Headquarters
Dover, Delaware, USA
Founded
-
Keros Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KROS. The last closing price for Keros Therapeutics was $13.66. Over the last year, Keros Therapeutics shares have traded in a share price range of $ 9.12 to $ 72.37.

Keros Therapeutics currently has 40,615,414 shares outstanding. The market capitalization of Keros Therapeutics is $554.81 million. Keros Therapeutics has a price to earnings ratio (PE ratio) of -2.92.

Ask ADVFN Intelligence (AI)

KROS Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
June 09 2025
KROS (-1.46%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 06 2025
KROS (-1.46%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 06 2025
KROS (-1.46%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 06 2025
KROS (-1.46%)

Form 8-K - Current report
Edgar (US Regulatory)
June 06 2025
KROS (-1.46%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.32-2.3222060957913.7814.04513.3464599513.70005655CS
4-0.64-4.539007092214.115.413.3467455314.23746068CS
122.0618.070175438611.415.49.12101042512.84011357CS
26-5.63-29.491880565719.0919.319.12118329712.45949208CS
52-35.84-72.697768762749.372.379.1285431822.2730054CS
156-14.65-52.116684453928.11739.1245957331.16261716CS
260-22.63-62.704350235536.0988.89.1233491834.84474024CS

KROS - Frequently Asked Questions (FAQ)

What is the current Keros Therapeutics share price?
The current share price of Keros Therapeutics is $ 13.46
How many Keros Therapeutics shares are in issue?
Keros Therapeutics has 40,615,414 shares in issue
What is the market cap of Keros Therapeutics?
The market capitalisation of Keros Therapeutics is USD 554.81M
What is the 1 year trading range for Keros Therapeutics share price?
Keros Therapeutics has traded in the range of $ 9.12 to $ 72.37 during the past year
What is the PE ratio of Keros Therapeutics?
The price to earnings ratio of Keros Therapeutics is -2.92
What is the cash to sales ratio of Keros Therapeutics?
The cash to sales ratio of Keros Therapeutics is 154
What is the reporting currency for Keros Therapeutics?
Keros Therapeutics reports financial results in USD
What is the latest annual turnover for Keros Therapeutics?
The latest annual turnover of Keros Therapeutics is USD 3.55M
What is the latest annual profit for Keros Therapeutics?
The latest annual profit of Keros Therapeutics is USD -187.35M
What is the registered address of Keros Therapeutics?
The registered address for Keros Therapeutics is 850 NEW BURTON ROAD, SUITE 201, DOVER, DELAWARE, 19904
What is the Keros Therapeutics website address?
The website address for Keros Therapeutics is www.kerostx.com
Which industry sector does Keros Therapeutics operate in?
Keros Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CEROCERo Therapeutics Holdings Inc
$ 19.92
(190.04%)
57.35M
ACXPAcurx Pharmaceuticals Inc
$ 0.8149
(165.35%)
337.39M
EYENEyenovia Inc
$ 6.96
(134.34%)
29.94M
RBNERobin Energy Ltd
$ 10.60
(92.03%)
45.44M
RELIReliance Global Group Inc
$ 2.20
(86.44%)
19.29M
SDSTStardust Power Inc
$ 0.186
(-52.10%)
39.42M
SHOTWSafety Shot Inc
$ 0.0161
(-45.97%)
12.35k
RUNSunrun Inc
$ 5.78
(-40.04%)
120.05M
SEDGSolarEdge Technologies Inc
$ 15.94
(-33.53%)
33.14M
GOVXGeoVax Labs Inc
$ 0.8924
(-32.39%)
2.64M
PCSAProcessa Pharmaceuticals Inc
$ 0.2632
(16.93%)
575.5M
GNLNGreenlane Holdings Inc
$ 0.0104
(-16.13%)
392.94M
HCTIHealthcare Triangle Inc
$ 0.022
(-16.67%)
356.57M
ACXPAcurx Pharmaceuticals Inc
$ 0.8149
(165.35%)
337.45M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 11.9373
(-7.75%)
143.55M

KROS Discussion

View Posts
TheFinalCD TheFinalCD 5 months ago
$KROS halts all dosing in the TROPOS Phase 2 clinical trial of cibotercept (KER-012) based on the ongoing safety review due to new observations of pericardial effusion adverse events

$KROS halts all dosing in the TROPOS Phase 2 clinical trial of cibotercept (KER-012) based on the ongoing safety review due to new observations of pericardial effusion adverse events— Bio Stocks™ (@BioStocks) January 15, 2025

$KROS the TROPOS trial is being terminated early. The Co continues to expect to present topline data from all treatment arms in this trial in Q2
$KROS the TROPOS trial is being terminated early. The Co continues to expect to present topline data from all treatment arms in this trial in Q2— Bio Stocks™ (@BioStocks) January 15, 2025
👍️0
retireat40 retireat40 6 months ago
Wow. What a turd 
👍️0
retireat40 retireat40 6 months ago
Shocked this is still sub 18
👍️0
Dennis14 Dennis14 6 months ago
Bought in at 18.00
👍️0
Monksdream Monksdream 9 months ago
KROS more upside possible

👍️0
Monksdream Monksdream 1 year ago
KROS new 52=week high
👍️0

Your Recent History

NASDAQ
KROS
Keros Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads